Happy to share our review on “Latest updates on cellular and molecular biomarkers of gliomas”. 🧬🧬 Very promising molecular and cytogenetic biomarkers for possible future treatment options. ⁦Hazem Assi⁩ ⁦⁦Maroun Bou Zerdan, MD⁩ frontiersin.org/articles/10.33…

Chemo-free combination of ponatinib + blinatumomab is potentially curative in Ph+ ALL w/o need for intensive chemo or allo-SCT. This is new standard of care in Ph+ ALL. Jabbour, Short, Kantarjian of MD Anderson Cancer Center #Leukemia authors.elsevier.com/a/1g5k18MsWYC4… via The Lancet Haematology #leusm

Extremely thrilled to be joining UPMC Hillman Cancer Center for Hematology Fellowship!! I am grateful for the support of my family, wife Rim Abou Chakra, MD and mentors Ali Taher iman aboudalle Dr jean elcheikh Nour Moukalled @ Ali Bazarbachi. To a new exciting journey!

Happy to share our case of the month published in the EBMT Newsletter about maintenance therapy post-transplant in T-ALL American University of Beirut Medical Center

Happy to attend #ASH_Highlights meeting in Istanbul. Very educational talks on the latest breakthrough treatments in malignant and classical hematology. ASH Ali Taher

Happy to share our work on the use of Clofarabine and TBI as conditioning regimen for allo-HCT in high risk leukemia. Honored to be part of this great work! Dr jean elcheikh iman aboudalle Nour Moukalled Mohamad Mohty

Honored to be inducted into the Gold Humansim Honor Society, AUB Chapter 2023! An award dedicated to people who inspired me to be the physician I am today. American University of Beirut Medical Center

Walking away from chemotherapy in Philadelphia+ #ALL presented by Pr. Elias Jabbour from MD Anderson Cancer Center ➡️ Proposed algorithm based on MRD evaluation ➡️ CAR-T cells +/- transplant for patients with persistent MRD #leusm

Exxcited that after almost a year of planning, #SOHO meeting of hematologic malignancies is coming to MENA region #SOHOMENA with the first #SOHOMENA23 taking place in Lebanon. A true pleasure to co-chair this outstanding program-Agenda to follow soon. bloodcancerstoday.com/post/soho-amba…

Glad to present our data on vulvar cancer characteristics and treatment in the MENA region at 7th MEMAGO conference in Egypt. #MEMAGO david atallah Nadine Kassis Basel_Refky

Dose-dense mini-hyper-CVD, INO and blina achieves NGS MRD negativity in >90% of pts with new dx B-ALL. A clinical trial at MD Anderson Cancer Center is ongoing. Nicholas Short MD Clinical Lymphoma, Myeloma and Leukemia clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

Out in Journal of Clinical Oncology Update dasatinib-Blina in Ph+ALL 👫63 pts 💊Dasatinib then sequential blina 🔹Molecular response 60% 🔹OS 81%, EFS 75% 🔸50% got HSCT 🔸9 relapses (7 T315I; 4 🧠) ➡️Effective & safe but NOT totally chemo-free regimen‼️ #OncoAlert #leusm doi.org/10.1200/JCO.23…

Sharing insights from our #CardioOncology study! Our findings emphasize the importance of interdisciplinary collaboration in managing cardiovascular issues in cancer patients 🫀 #MedEd Omar Fakhreddine Dr. Hadi Skouri Ali Atoui, MD Ali Taher American University of Beirut Medical Center researchsquare.com/article/rs-360…

#EHA24 Pleanry session: Glo-GEMOX in R/R DLBCL compared to R-GEMOX in Phase III STARGLO Trial. Significant better OS, PFS and CR rate. Toxicities are tolerable, with CRS mostly low grade.

Congratulations david atallah. Well deserved!

Even though ASH was a week ago, the excitement is still going strong! Can't stop thinking about all the incredible sessions and discussions from ASH last week, so many amazing insights and connections made #ASH24 #Hematology ASH

Extremely thrilled to have been selected for the International Journal of Gynecological Cancer IJGC fellowship. Very excited to learn about research in gynecological oncology from renowned scientists in the field. IJGC Fellows david atallah

Glad to have been awarded the CHAMP award from the American Society of Hematology ASH for 2025! Very excited to meet mentors and receive valuable guidance in the field.

ASH Hematology Focused Fellowship Accomplished! Grateful to my family, mentors and friends for the unwavering support! Looking forward to the next step! ASH UPMC Heme-Onc Fellowship Program

Honored to have been selected as an ASH Ambassador for this year! Excited to be part of this program and support the next generation of hematologists. ASH UPMC Heme-Onc Fellowship Program Pitt Hematology